Regenerative Dentistry Market Report 2026

The regenerative dentistry market size has grown strongly in recent years. It will grow from $2.7 billion in 2025 to $2.96 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to increasing prevalence of dental disorders, advancements in biomaterial research, rising awareness of regenerative dental procedures, growth in specialized dental clinics, early adoption of tissue engineering approaches.

The regenerative dentistry market size is expected to see strong growth in the next few years. It will grow to $4.28 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing investments in regenerative medicine research, rising demand for minimally invasive dental solutions, expansion of clinical trials for bioengineered teeth, growing acceptance of biologic dental treatments, technological progress in scaffold and growth factor development. Major trends in the forecast period include increasing adoption of stem cell-based dental therapies, rising use of bioactive and biomimetic materials, growing focus on pulp and periodontal regeneration, expansion of personalized regenerative dental treatments, enhanced integration of advanced tissue engineering techniques.

The growing prevalence of periodontal diseases is expected to significantly drive the growth of the regenerative dentistry market in the coming years. Periodontal diseases are inflammatory infections affecting the tissues that support teeth, including the gums, periodontal ligament, and alveolar bone, often causing swollen gums, bleeding, and in severe cases, tooth loss. This rise is largely driven by poor oral hygiene, which leads to plaque accumulation and subsequent gum infections. Regenerative dentistry addresses this need by restoring damaged gum and bone tissues through advanced biomaterials and emerging stem cell-based therapies. For example, according to Mint Dental Centre, a UK-based dental care provider, the proportion of the UK population affected by gum disease is projected to increase from 42% in 2025 to 54% by 2050, indicating a substantial upward trend. Consequently, the increasing prevalence of periodontal diseases is propelling the regenerative dentistry market.

Major companies in the regenerative dentistry market are focusing on advancements in restorative regenerative techniques, such as allograft bone in a syringe, to improve bone grafting efficiency, enhance clinical outcomes, and simplify surgical procedures for dental professionals. Allograft bone in a syringe is a ready-to-use bone graft material derived from donor human bone tissue, processed, sterilized, and packaged in a pre-filled syringe to ensure precision and convenience during dental or surgical procedures. For instance, in July 2024, TBS Dental LLC, a US-based dental solutions company, launched the REGEN product line, which includes bone particulate in a curved-syringe applicator, a jar-format mineralized cortico-cancellous graft, and a resorbable collagen membrane with high tensile strength and excellent contour ability for socket preservation and soft-tissue regeneration.

In June 2023, Solmetex LLC, a US-based provider of dental amalgam separators and environmental compliance solutions, acquired Impladent Ltd. for an undisclosed amount. Through this acquisition, Solmetex LLC aims to expand its global presence and enhance its dental waste management product portfolio. Impladent Ltd., also US-based, provides dental instruments and implantology products, offering precision tools and solutions for dental practices.

Major companies operating in the regenerative dentistry market are Stryker Corporation, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Dentsply Sirona, Arthrex Inc., Integra LifeSciences Corporation, Nobel Biocare, Organogenesis Holdings Inc., Osstem Implant, MiMedx Group Inc., Vericel Corporation, LifeNet Health, BioTissue Holdings Inc., Geistlich Pharma AG, RTI Surgical Holdings Inc., Tissue Regenix Group plc, Viscus Biologics, Botiss Biomaterials GmbH, Revivicor Inc., Genoss Co. Ltd.

North America was the largest region in the regenerative dentistry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the regenerative dentistry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the regenerative dentistry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the regenerative dentistry market by increasing the cost of imported biomaterials, stem cell processing equipment, laboratory reagents, and specialized manufacturing tools used in tissue engineering and regenerative applications. Dental research centers and clinics in North America and Europe are most affected due to dependence on imported biologics and precision equipment, while Asia-Pacific faces cost pressures in material sourcing. These tariffs are increasing treatment costs and slowing technology adoption in smaller practices. However, they are also encouraging domestic biomaterial production, local research collaborations, and regional manufacturing of regenerative dental products.

The regenerative dentistry market research report is one of a series of new reports that provides regenerative dentistry market statistics, including regenerative dentistry industry global market size, regional shares, competitors with a regenerative dentistry market share, detailed regenerative dentistry market segments, market trends and opportunities, and any further data you may need to thrive in the regenerative dentistry industry. This regenerative dentistry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Regenerative dentistry is a branch of dental science dedicated to restoring damaged or lost oral tissues, including teeth, bone, and gums, using biological and tissue engineering approaches. It employs stem cells, biomaterials, and growth factors to activate the body’s natural healing mechanisms. The primary goal of regenerative dentistry is to regenerate functional dental tissues rather than replace them with artificial materials, with applications such as pulp and periodontal regeneration, bone reconstruction, and potential development of bioengineered teeth.

The main types of regenerative dentistry materials include natural and synthetic options. Natural materials are biologically derived, such as autografts, allografts, xenografts, collagen membranes, and platelet-rich derivatives, which support the body’s innate healing and tissue formation processes. These materials are used for both hard and soft tissue reconstruction and are applied through technologies like tissue engineering, stem cell therapy, and others. Their applications include periodontal regeneration, endodontic regeneration, tooth reconstruction, bone regeneration, and more, serving end users such as hospitals, dental clinics, and other healthcare settings.

The regenerative dentistry market includes revenues earned by entities by providing services such as periodontal tissue regeneration, pulp-dentin regeneration, alveolar bone grafting and ridge augmentation, guided tissue regeneration (GTR), and platelet-rich fibrin (PRF) or platelet-rich plasma (PRP) procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.